HALPRYN GLENN L

CIK 00009384398 companiesMIAMI, FL

SEC Profile

Transactions

Companies

Filings

CIK

0000938439

Recent Transactions

43 trades

Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2015-07-06+75,000→ 339,309 total
Award
Castle Brands Inc
Stock Option (Right to Buy)
2015-03-26+20,000→ 20,000 total
Award
Castle Brands Inc
Stock Option (Right to Buy)
2014-03-05+20,000→ 20,000 total
Exercise/Conversion
Castle Brands Inc
10% Series A Convertible Preferred Stock
2014-02-24−209.192→ 0 total
Exercise/Conversion
Castle Brands Inc
Common Stock
2014-02-24$0.30/sh+850,834→ 1,194,900 total
Exercise/Conversion
Castle Brands Inc
Common Stock
2014-02-21$0.38/sh+344,066→ 344,066 total
Exercise/Conversion
Castle Brands Inc
Common Stock Purchase Warrants
2014-02-21−344,066→ 0 total
Award
Niagen Bioscience, Inc.$NAGE
Common Stock
2014-01-21+10,000→ 10,000 total
Award
Castle Brands Inc
5% Subordinated Convertible Note due 2018
2013-10-31$200000.00/sh
Exercise of In-Money
Niagen Bioscience, Inc.$NAGE
Common Stock
2013-02-12$0.21/sh+535,714→ 1,271,428 total
Exercise of In-Money
Niagen Bioscience, Inc.$NAGE
Warrants to Purchase Common Stock
2013-02-12−535,714→ 0 total
Disposition to Issuer
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-12-21−82,500→ 82,500 total
Disposition to Issuer
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-12-21−82,500→ 165,000 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-12-21+106,809→ 189,309 total
Award
Castle Brands Inc
Stock Option (Right to Buy)
2012-10-15+20,000→ 20,000 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2012-08-28+82,500→ 247,500 total
Purchase
Niagen Bioscience, Inc.$NAGE
Common Stock
2012-02-10$0.75/sh+200,000→ 735,714 total
Award
Sorrento Therapeutics, Inc.
Non-qualified stock option
2012-02-06+140,000→ 140,000 total
Purchase
Castle Brands Inc
Common Stock Purchase Warrants
2011-10-14+344,066→ 344,066 total
Purchase
Castle Brands Inc
10% Series A Convertible Preferred Stock
2011-10-14$1000.00/sh+209.192→ 209.192 total
Award
Castle Brands Inc
Stock Option (Right to Buy)
2011-09-12+20,000→ 20,000 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2011-05-10+82,500→ 82,500 total
Award
Sorrento Therapeutics, Inc.
Non-qualified stock option
2011-04-15+7,500→ 87,500 total
Award
Sorrento Therapeutics, Inc.
Non-qualified stock option
2010-11-29+30,000→ 80,000 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2010-05-20+82,500→ 82,500 total
Award
Niagen Bioscience, Inc.$NAGE
Employee Stock Options (right to buy)
2010-05-20−82,500→ 82,500 total
Award
Sorrento Therapeutics, Inc.
Non-qualified stock option
2010-02-05+10,000→ 50,000 total
Award
Castle Brands Inc
Stock Option (Right to Buy)
2010-02-04+20,000→ 20,000 total
Award
Fluent, Inc.$FLNT
Stock Option (Right to Buy)
2010-01-11+25,000→ 25,000 total
Other
Fluent, Inc.$FLNT
Ordinary Shares, par value $0.0001 per share
2009-10-30+12,688→ 12,688 total
Other
Fluent, Inc.$FLNT
Warrant
2009-10-30+3,172→ 3,172 total
Other
Fluent, Inc.$FLNT
Ordinary Shares, par value $0.0001 per share
2009-10-30+12,688→ 12,668 total
Award
Winston Pharmaceuticals, Inc.
Common Stock Options
2009-09-25+30,000→ 30,000 total
Conversion
Winston Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2009-09-24−229→ 0 total
Conversion
Winston Pharmaceuticals, Inc.
Common Stock
2009-09-24+229,000→ 354,781 total
Award
Sorrento Therapeutics, Inc.
Option to Purchase Common Stock
2009-09-21+40,000→ 40,000 total
Purchase
Sorrento Therapeutics, Inc.
Common Stock
2009-09-18$0.04/sh+781,102→ 781,102 total
Purchase
Sorrento Therapeutics, Inc.
Common Stock
2009-09-18$0.04/sh+17,184,228→ 17,184,228 total
Conversion
Castle Brands Inc
Common Stock
2009-02-17+2,857,144→ 2,857,144 total
Conversion
Castle Brands Inc
Series A Convertible Preferred Stock
2009-02-17−80,000→ 0 total
Award
Castle Brands Inc
Stock Option (Right to Buy)
2009-01-21+20,000→ 20,000 total
Other
Winston Pharmaceuticals, Inc.
Common Stock, par value $0.001 per share
2008-09-25+1,833,284→ 2,839,534 total
Award
ERBA Diagnostics, Inc.
Stock Option (Right to Buy)
2005-07-13+25,000→ 25,000 total

HALPRYN GLENN L

Recent Transactions

Companies

Recent Filings

Address